跳至主要内容
临床试验/CTRI/2019/08/020797
CTRI/2019/08/020797尚未招募2 期

PHASE II NON-RANDOMIZED OPEN CLINICAL EVALUATION OF SIDDHA DRUG THEER ANDHASKHAN MATHIRAI FOR UTHIRAVAATHA SURONITHAM (RHEUMATOID ARTHRITIS)-IN BOTH GENDER OF AGE BETWEEN 18 TO 50 YEARS PATIENTS ATTENDING OPD AT AAGHIM ATTACHED WITH GSMC

Government Siddha Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age limit - 18 to 50 years
  • Both the Gender(Even though a female specific disorder)
  • Morning stiffness more than 1 hour
  • Arthritis of hand joints
  • Arthritis of 3 or more joints
  • Symmetrical arthritis
  • Anti-cyclic citrullinated Peptide (Anti CCP) Positive

排除标准

  • Age below 18 and above 50 years
  • Rheumatic fever
  • Psoriatic arthropathy
  • Reiters syndrome
  • Gouty arthritis
  • Systemic Lupus Erythematosus
  • Progressive systemic sclerosis
  • Pregnant women and lactating mothers
  • Any other serious systemic illness
  • will be excluded clinically or based on medical reports

研究者

发起方
Government Siddha Medical College

相似试验